Cargando…

The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review

BACKGROUND: Catheter infections remain one of the most persistent adverse events causing significant morbidity, economic impact and mortality. Several strategies have been proposed to reduce these infections including the use of catheters embedded with antibiotics and/or antiseptics. One reoccurring...

Descripción completa

Detalles Bibliográficos
Autores principales: Reitzel, Ruth A, Rosenblatt, Joel, Gerges, Bahgat Z, Jarjour, Andrew, Fernández-Cruz, Ana, Raad, Issam I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210168/
https://www.ncbi.nlm.nih.gov/pubmed/34222960
http://dx.doi.org/10.1093/jacamr/dlaa002
_version_ 1783709257499148288
author Reitzel, Ruth A
Rosenblatt, Joel
Gerges, Bahgat Z
Jarjour, Andrew
Fernández-Cruz, Ana
Raad, Issam I
author_facet Reitzel, Ruth A
Rosenblatt, Joel
Gerges, Bahgat Z
Jarjour, Andrew
Fernández-Cruz, Ana
Raad, Issam I
author_sort Reitzel, Ruth A
collection PubMed
description BACKGROUND: Catheter infections remain one of the most persistent adverse events causing significant morbidity, economic impact and mortality. Several strategies have been proposed to reduce these infections including the use of catheters embedded with antibiotics and/or antiseptics. One reoccurring challenge is the fear that antimicrobial medical devices will induce resistance. The aim of this systematic review is to evaluate the evidence for induced antimicrobial resistance caused by exposure to antimicrobial medical devices. METHODS: Four electronic databases [MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus] were screened for studies published between 1983 and 2019 regarding assessment of microbial resistance with use of medical devices containing chlorhexidine, minocycline, rifampicin or combinations thereof. Development of new resistance, selection for tolerant organisms and ‘no change in resistance’ were assessed. RESULTS: Forty-four publications, grouped by study type and stratified by drug assessed, were included for analyses. The majority of studies found no change in resistance after exposure to antimicrobial medical devices (13 in vitro, 2 in vivo, 20 clinical). Development of new resistance was commonly reported with the use of rifampicin as a single agent and only reported in one study assessing the minocycline/rifampicin combination (M/R); however, the increase in MIC was well below clinical relevance. CONCLUSIONS: Emergence of new resistance to combinations of M/R, minocycline/rifampicin/chlorhexidine (M/R/CH) and chlorhexidine/silver sulfadiazine (CHXSS) was rare. No clinical trials confirmed its occurrence and some refuted it. The risk of development of new resistance to these antimicrobial combinations appears more fear-based than substantiated by clinical and experimental evidence but warrants continued surveillance.
format Online
Article
Text
id pubmed-8210168
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82101682021-07-02 The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review Reitzel, Ruth A Rosenblatt, Joel Gerges, Bahgat Z Jarjour, Andrew Fernández-Cruz, Ana Raad, Issam I JAC Antimicrob Resist Systematic Review BACKGROUND: Catheter infections remain one of the most persistent adverse events causing significant morbidity, economic impact and mortality. Several strategies have been proposed to reduce these infections including the use of catheters embedded with antibiotics and/or antiseptics. One reoccurring challenge is the fear that antimicrobial medical devices will induce resistance. The aim of this systematic review is to evaluate the evidence for induced antimicrobial resistance caused by exposure to antimicrobial medical devices. METHODS: Four electronic databases [MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus] were screened for studies published between 1983 and 2019 regarding assessment of microbial resistance with use of medical devices containing chlorhexidine, minocycline, rifampicin or combinations thereof. Development of new resistance, selection for tolerant organisms and ‘no change in resistance’ were assessed. RESULTS: Forty-four publications, grouped by study type and stratified by drug assessed, were included for analyses. The majority of studies found no change in resistance after exposure to antimicrobial medical devices (13 in vitro, 2 in vivo, 20 clinical). Development of new resistance was commonly reported with the use of rifampicin as a single agent and only reported in one study assessing the minocycline/rifampicin combination (M/R); however, the increase in MIC was well below clinical relevance. CONCLUSIONS: Emergence of new resistance to combinations of M/R, minocycline/rifampicin/chlorhexidine (M/R/CH) and chlorhexidine/silver sulfadiazine (CHXSS) was rare. No clinical trials confirmed its occurrence and some refuted it. The risk of development of new resistance to these antimicrobial combinations appears more fear-based than substantiated by clinical and experimental evidence but warrants continued surveillance. Oxford University Press 2020-02-21 /pmc/articles/PMC8210168/ /pubmed/34222960 http://dx.doi.org/10.1093/jacamr/dlaa002 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Systematic Review
Reitzel, Ruth A
Rosenblatt, Joel
Gerges, Bahgat Z
Jarjour, Andrew
Fernández-Cruz, Ana
Raad, Issam I
The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
title The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
title_full The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
title_fullStr The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
title_full_unstemmed The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
title_short The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
title_sort potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210168/
https://www.ncbi.nlm.nih.gov/pubmed/34222960
http://dx.doi.org/10.1093/jacamr/dlaa002
work_keys_str_mv AT reitzelrutha thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT rosenblattjoel thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT gergesbahgatz thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT jarjourandrew thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT fernandezcruzana thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT raadissami thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT reitzelrutha potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT rosenblattjoel potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT gergesbahgatz potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT jarjourandrew potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT fernandezcruzana potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview
AT raadissami potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview